With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

A smart company takes care of its best

Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.

Dako appoints new CEO

The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

Ten recieve the Venture Cup West Prize

At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

SDU professor helps EU

Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.

New Nordic nutrition collaboration

Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.

Medtech giant separates

Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

Glucose facilitates the use of indigo

The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.

Sales Representative, Applied Biosystems

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young researchers. It isn't the first award for the Associate Professor at Gothenburg University's Sahlgrenska Academy. In 2007, he received a grant award of 16 million SEK from the European Research Council for his pioneering work.